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Purpose/Objective(s): Local recurrence rates in reported series of chordoma patients 
following treatment with surgery ± radiation therapy (RT) or definitive RT are high. Tumor 
hypoxia is associated with radioresistance and local recurrence in animal models and human 
patients. [18F] fluoromisonidazole positron emission tomography/computed tomography 
(FMISO-PET/CT) has been used to visualize hypoxic sub-volumes (HSV) in skull base 
chordoma and the feasibility of its use in RT dose-escalation has been demonstrated in head 
and neck cancer. The feasibility of FMISOPET/CT use for detection of targetable HSVs in 
patients with chordoma of the mobile and sacrococcygeal spine is unknown and 
investigated in the current study. 
Materials/Methods: A prospective, pilot study of 20 patients with primary or locally 
recurrent chordoma of the mobile or sacrococcygeal spine treated with proton or combined 
proton/photon RT ± surgery was completed. FMISO-PET/CT was performed prior to RT and 
again after 19.8-34.2 GyRBE (relative biologic effectiveness). Gross tumor volumes were 
delineated and HSVs defined including all voxels with a standardized uptake value (SUV) ≥ 
1.4 times the mean muscle SUV. The pre-specified threshold for FMISO-PET/CT feasibility 
was positive tracer uptake in 4/20 patients. Distributions of clinical characteristics and 
treatments received were compared between patients with and without HSVs. Treatment 
outcomes are reported. 
Results: FMISO-PET/CT detected HSVs in 12 (60%; 12/20) patients, 8 of which were of 
sufficient size (≥  5 cc) to potentially allow for delivery of an intensity modulated proton 
therapy boost. Patients with HSVs had significantly larger gross tumor volumes (median = 
410.0 cc vs 63.4 cc; p = 0.02) and were significantly more likely to have stage T2 tumors 
(5/12vs 0/8; p = 0.04) compared to those without HSVs. After a median followup of 1.8 
years (range: 0.2-4.4), a local recurrence has yet to be observed. Three patients developed 
metastatic disease, 2 of whom had HSVs. 
Conclusions: FMISO-PET/CT is feasible for detection of targetable HSVs within patients 
undergoing RT ± surgery for treatment of chordoma of the mobile and sacrococcygeal spine. 
Further study of its application in hypoxia-directed, dose-escalated RT, particularly in 
patients at high risk for local recurrence, is warranted. 
 
